Nil Molinas Mandel

4PUBLICATIONS
36CO-AUTHORS
Medical biotechnology not elsewhere classifiedTumour immunologyImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638.

Ziya Kalkan, Senar Ebinc, Murat Arcagok

|Apr 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study.

Ziya Kalkan, Senar Ebinc, Murat Arcagok

|Jul 17, 2020
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy.

Necdet Uskent, Sule Ayla, Nil Molinas Mandel

|Jan 24, 2020
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Atakan Demir, Nil Molinas Mandel, Semra Paydas

Pageof 1

Frequent Collaborators

2 joint publications

Ahmet Bilici

2 joint publications

Serdar Karakaya

2 joint publications

Deniz Can Guven

2 joint publications

Murat Arcagok